logo

For the Inventor, By the Inventor

Mumbai, India

Glenmark Pharmaceuticals Limited


USPTO Granted Patents = 33

% Expired Patents = 60.6


Forward Citations = 96

Loading Chart...
Loading Chart...

120 inventors (with patents filed for the assignee):

goldMedal Shekhar Bhaskar Bhirud (19 out of 28 patents)

silverMedal Samir Naik (7 out of 10 patents)

bronzeMedal Sachin Srivastava (5 out of 5 patents)

4.  Ulhas R Dhuppad (4 out of 24 patents)

5.  Kumar Hari Bhushan (4 out of 6 patents)

6.  Sushanta Mishra (4 out of 5 patents)

7.  Sukumar Sinha (3 out of 8 patents)

8.  Rajesh Ankam (3 out of 13 patents)

9.  Suresh Babu Narayanan (3 out of 3 patents)

10.  Bobba Venkata Siva Kumar (3 out of 4 patents)

11.  Batchu Chandrasekhar (3 out of 3 patents)

12.  Michael Crick (3 out of 3 patents)

13.  Ashok Katkurwar (2 out of 12 patents)

14.  Julianne Berry (2 out of 4 patents)

15.  Dilipkumar Jibhau Patil (2 out of 2 patents)


Core Competencies:
Metered Dose Inhalers
Fluticasone
Ipratropium Bromide
Dry Powder Inhaler
Dipeptidyl Peptidase Inhibitors
Efinaconazole
Canagliflozin
Rivaroxaban
Apixaban
Teneligliptin
Mometasone
Perindopril

33 patents:

1. 12514996 - Metered dose inhalers of fluticasone or an ester thereof (2026-01-06),
2. 12514995 - Metered dose inhalers of fluticasone or an ester thereof (2026-01-06),
3. 12502489 - Metered dose inhaler for ipratropium bromide solution (2025-12-23),
4. D914095 - Label (2021-03-23),
5. 10357622 - Dry powder inhaler (2019-07-23),
6. 10138206 - Amorphous form of lomitapide mesylate (2018-11-27),
7. 10138190 - Process for preparation of ospemifene (2018-11-27),
8. 10125115 - Process for the preparation of efinaconazole (2018-11-13),
9. 10106483 - Process for preparation of azelaic acid (2018-10-23),
10. 9840456 - Process for preparation of dimethyl fumarate (2017-12-12),
11. D804015 - Inhaler (2017-11-28),
12. 9776985 - Process for preparation of alogliptin (2017-10-03),
13. D797920 - Inhaler (2017-09-19),
14. 9695159 - Process for preparation of canagliflozin (2017-07-04),
15. 9670160 - Process for the preparation of tofacitinib and intermediates thereof (2017-06-06),
Company Overview
Glenmark Pharmaceuticals Limited is a global pharmaceutical company headquartered in Mumbai, India, specializing in the development and manufacturing of a diverse range of generic and branded medications. The company focuses on therapeutic areas such as dermatology, oncology, and respiratory diseases, leveraging advanced research and development capabilities. Glenmark is committed to innovation in drug delivery systems and biologics, aiming to enhance patient care through effective and accessible healthcare solutions worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Glenmark Pharmaceuticals Limited USPTO Patent Assignee Logo
33 Patents

#14 in Mumbai

#61 in India

#20,130 in the World

Mumbai, IN
Mumbai, India

Glenmark Pharmaceuticals Limited

Forward Citations = 96

120 inventors:

goldMedal Shekhar Bhaskar Bhirud (19 out of 28 patents)

silverMedal Samir Naik (7 out of 10 patents)

bronzeMedal Sachin Srivastava (5 out of 5 patents)

4.  Ulhas R Dhuppad (4 out of 24 patents)

5.  Kumar Hari Bhushan (4 out of 6 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Glenmark Pharmaceuticals Limited. Retrieved from https://idiyas.com/company/glenmark-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…